{
    "2021-08-13": [
        [
            {
                "time": "",
                "original_text": "半年报：8成药企业绩增长",
                "features": {
                    "keywords": [
                        "半年报",
                        "药企",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "通策医疗：宝群实业质押股份总数为4300万股",
                "features": {
                    "keywords": [
                        "通策医疗",
                        "宝群实业",
                        "质押",
                        "股份"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "通策医疗(600763.SH)控股股东宝群实业质押250万股及解质350万股",
                "features": {
                    "keywords": [
                        "通策医疗",
                        "控股股东",
                        "宝群实业",
                        "质押",
                        "解质"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "亏损72亿终止IPO，依出售医疗业务；中国人成世界第一胖",
                "features": {
                    "keywords": [
                        "亏损",
                        "IPO",
                        "依图",
                        "医疗业务",
                        "中国人",
                        "肥胖"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "8成药企业绩增长，这些企业净利润表现亮眼",
                "features": {
                    "keywords": [
                        "药企",
                        "业绩增长",
                        "净利润"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "百亿私募重仓股曝光，二季度加仓周期板块",
                "features": {
                    "keywords": [
                        "私募",
                        "重仓股",
                        "二季度",
                        "加仓",
                        "周期板块"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "周期"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}